Oncolytics Biotech
ONCY
#9325
Rank
A$0.13 B
Marketcap
A$1.26
Share price
5.89%
Change (1 day)
1.28%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -A$38.66 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$36.25 Million a decrease over its 2023 earnings that were of -A$35.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.66 Million6.64%
2024 -A$36.25 Million1.01%
2023 -A$35.89 Million23.39%
2022 -A$29.09 Million-1.98%
2021 -A$29.67 Million9.1%
2020 -A$27.2 Million22.64%
2019 -A$22.18 Million22.78%
2018 -A$18.06 Million4.1%
2017 -A$17.35 Million4.87%
2016 -A$16.55 Million8.75%
2015 -A$15.22 Million-37.06%
2014 -A$24.17 Million-26.2%
2013 -A$32.75 Million-37.39%
2012 -A$52.31 Million28.8%
2011 -A$40.62 Million46.02%
2010 -A$27.82 Million35.64%
2009 -A$20.51 Million-14.2%
2008 -A$23.9 Million-0.52%
2007 -A$24.03 Million24.6%
2006 -A$19.28 Million45.34%
2005 -A$13.27 Million-11.8%
2004 -A$15.04 Million115.36%
2003 -A$6.99 Million13.86%
2002 -A$6.14 Million-5.45%
2001 -A$6.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$32.06 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.44 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.09 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.82 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.52 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$41.38 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA